Continual Reassessment Method
Showing 1 - 25 of >10,000
B Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial (Decreasing starting times for beginning
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Acute Lymphoblastic Leukemia, in Relapse
- Decreasing starting times for beginning nivolumab (Time to Event Continual Reassessment Method (TITE-CRM) )
- Nivolumab starting at day -1
- (no location specified)
Apr 4, 2022
Oesophageal Adenocarcinoma, Squamous Cell Carcinoma, Solid Tumor Trial in United Kingdom (M6620, Cisplatin, Capecitabine)
Completed
- Oesophageal Adenocarcinoma
- +2 more
- M6620
- +3 more
-
Cardiff, United Kingdom
- +4 more
Apr 27, 2022
Pregnant Women Trial in Brussels Capital Region (HB Prilocaine 2% (varying dose), HB Prilocaine 2%, Sufentanil)
Completed
- Pregnant Women
- HB Prilocaine 2% (varying dose)
- +3 more
-
Brussels Capital Region, BelgiumUniversity Hospital Saint-Pierre, Université Libre de Bruxelles
Apr 24, 2020
Post Operative Pain Trial in Seattle (Dose of 0.5% Ropivacaine)
Recruiting
- Post Operative Pain
- Dose of 0.5% Ropivacaine
-
Seattle, WashingtonVirginia Mason Medical Center
May 11, 2023
ive Dose 95 of Intrathecal Isobaric 2-chloroprocaine Based on
Completed
- Knee Arthroscopy
- Isobaric 2-chloroprocaine
-
Braine-l'Alleud,, BelgiumBraine-l'Alleud Hospital
Oct 4, 2019
Medication Adherence Trial in Manhasset (5 Behavioral Change Techniques)
Recruiting
- Medication Adherence
- 5 Behavioral Change Techniques
-
Manhasset, New YorkNorthwell Health
Jul 12, 2023
Medication Adherence Trial in New York (5 Behavioral Change Techniques)
Recruiting
- Medication Adherence
- 5 Behavioral Change Techniques
-
New York, New YorkInstitute of Health System Science
Sep 6, 2022
Non Small Cell Lung Cancer Trial in Canada (SBRT)
Active, not recruiting
- Non Small Cell Lung Cancer
- SBRT
-
Vancouver, British Columbia, Canada
- +6 more
Apr 12, 2022
Insufficient Physical Activity Trial in New York (5 Behavioral Change Techniques)
Recruiting
- Insufficient Physical Activity
- 5 Behavioral Change Techniques
-
New York, New YorkInstitute of Health System Science
May 17, 2022
Lung Cancer Trial in Heidelberg (Stereotactic body radiotherapy (SBRT))
Recruiting
- Lung Cancer
- Stereotactic body radiotherapy (SBRT)
-
Heidelberg, GermanyUniversity Hospital of Heidelberg, Radiation Oncology
Nov 2, 2022
Locally Advanced NSCLC Trial in Edinburgh, London, Oxford (Atovaquone Oral Suspension, Standard of care chemo, Standard of care
Recruiting
- Locally Advanced Non-Small Cell Lung Cancer
- Atovaquone Oral Suspension
- +2 more
-
Edinburgh, United Kingdom
- +1 more
Dec 21, 2021
Hematological Malignancies Trial in Durham (fostamatinib)
Active, not recruiting
- Hematological Malignancies
-
Durham, North CarolinaDuke University of Medicine
Jul 14, 2022
Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
-
Nantes, FranceCHU of Nantes
Dec 16, 2022
Neonatal Seizure, Neonatal Encephalopathy, Hypoxic-Ischemic Encephalopathy Trial in San Diego (Levetiracetam Injection,
Not yet recruiting
- Neonatal Seizure
- +3 more
- Levetiracetam Injection
- Phenobarbital Sodium Injection
-
San Diego, CaliforniaUniversity of California, San Diego
Nov 6, 2022
Breast Cancer Trial (Reimbursement)
Not yet recruiting
- Breast Cancer
- Reimbursement
- (no location specified)
May 22, 2023
Adult Patients With Adverse Risk Acute Myeloblastic Leukemia Trial (Darzalex)
Not yet recruiting
- Adult Patients With Adverse Risk Acute Myeloblastic Leukemia
- (no location specified)
Feb 27, 2023
Laceration Repair Trial in London (Dexmedetomidine)
Completed
- Laceration Repair
-
London, Ontario, CanadaLondon Health Sciences Centre
Apr 5, 2022
Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Recombinant Interleukin-7
-
Houston, TexasM D Anderson Cancer Center
Jan 26, 2023
Head Neck Cancer Trial in Milwaukee (46 Gy Radiation Therapy, 40 Gy Radiation Therapy, 35 Gy Radiation Therapy)
Not yet recruiting
- Head and Neck Cancer
- 46 Gy Radiation Therapy
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Sep 9, 2022
Advanced Adult Hepatocellular Carcinoma Trial in Chicago, Ann Arbor, Dallas (Cabozantinib)
Recruiting
- Advanced Adult Hepatocellular Carcinoma
-
Chicago, Illinois
- +3 more
Aug 15, 2022
Recurrent Glioblastoma Trial (Niraparib, Re-irradiation (re-RT))
Not yet recruiting
- Recurrent Glioblastoma
- Niraparib
- Re-irradiation (re-RT)
- (no location specified)
Dec 23, 2022
Pancreatic Carcinoma Non-resectable Trial in Ottawa (CyberKnife® Stereotactic Body Radiotherapy(SBRT)Boost)
Terminated
- Pancreatic Carcinoma Non-resectable
- CyberKnife® Stereotactic Body Radiotherapy(SBRT)Boost
-
Ottawa, Ontario, CanadaThe Ottawa Hospital Cancer Centre
Apr 13, 2020
Chronic Lung Disease of Prematurity, Respiratory Distress Syndrome in Premature Infant, Bronchopulmonary Dysplasia Trial
Not yet recruiting
- Chronic Lung Disease of Prematurity
- +2 more
- Recombinant fragment of human surfactant protein D (rfhSP-D)
- (no location specified)
Jun 6, 2023